BRIEF-Nektar Therapeutics Announces Pricing Of Upsized $400 Million Public Offering
Reuters
Feb 12
BRIEF-Nektar Therapeutics Announces Pricing Of Upsized $400 Million Public Offering
Feb 11 (Reuters) - Nektar Therapeutics NKTR.O:
NEKTAR THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $400 MILLION PUBLIC OFFERING
NEKTAR THERAPEUTICS - SHARES SOLD AT $58.00 PER SHARE
Source text: ID:nPn7xzJ0ta
Further company coverage: NKTR.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.